Pharmaceutical cocrystals of Efavirenz: Towards the improvement of solubility, dissolution rate and stability

被引:9
作者
Gowda, B. H. Jaswanth [1 ,3 ]
Nechipadappu, Sunil Kumar [2 ]
Shankar, S. J. [3 ]
Chavali, Murthy [4 ,5 ]
Paul, Karthika [3 ]
Ahmed, Mohammed Gulzar [1 ]
Sanjana, A. [1 ]
Shanthala, H. K. [6 ]
机构
[1] Yenepoya Univ, Yenepoya Pharm Coll & Res Ctr, Dept Pharmaceut, Mangalurum 575018, India
[2] Natl Inst Technol Karnataka NITK, Dept Chem, Mangaluru 575025, India
[3] Vivekananda Coll Pharm, Dept Pharmaceut, Bengaluru 560055, India
[4] NTRC MCETRC, Dept Mat, Tenali 522201, India
[5] Aarshanano Composite Technol Pvt Ltd, Tenali 522201, India
[6] Sri Siddhartha Acad Higher Educ, Dept Chem, Tumakuru 572107, India
关键词
Pharmaceutical cocrystal; Dissolution rate; Solubility; Efavirenz; Non-nucleoside reverse transcriptase inhibitors; Coformer; ACID; ENHANCEMENT; STRATEGIES; SACCHARIN; DRUGS;
D O I
10.1016/j.matpr.2021.05.535
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Efavirenz (EFV) is a Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI) class of antiretroviral drug that is included in antiretroviral therapy to treat Human Immunodeficiency Virus (HIV) patients to increase the life-span by avoiding them to develop Acquired Immune Deficiency Syndrome (AIDS). One of the major drawbacks of EFV is its solubility in purified water (0.093 mg/L). In the present work, two cocrystals of EFV using tartaric acid (TAR) and adipic acid (ADP) as coformers that are Generally Recognized as Safe (GRAS) are reported. Both the EFV-TAR and EFV-ADP cocrystals were developed using slow solvent evaporation technique and further characterization of developed cocrystal structures was done by Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR), Differential scanning calorimetry (DSC) and Powder x-ray diffraction (PXRD) techniques. The SEM photomicrographs indicated that the EFV-TAR cocrystals were in needle shape with smooth surface. Its length ranged from 100 to 300 mm. The EFV-ADP cocrystals were found to be flaky needle shape with rough surface bearing irregular edges whose length ranged about 50-400 mm. The FT-IR spectra of both developed cocrystals confirmed the formation of a hydrogen bond between EFV and coformers by indicating a notable shift in -C=O functional group. The DSC and PXRD studies were further confirmed the successful development of a novel crystalline form (Cocrystal). The solubility (25 +/- 0.5 degrees C) of EFV-TAR and EFV-ADP cocrystals were found to be 163 and 107 lg/mL respectively, whereas pure EFV showed 94 mu g/mL. The dissolution rate (37 +/- 0.5 degrees C) of EFV-TAR and EFV-ADP cocrystals in 1% sodium lauryl sulphate (SLS) solution demonstrated 1.4 and 1.2 times increment respectively, compared to the pure EFV. The developed EFV-TAR and EFV-ADP cocrystals were found to stable for 6 months in ambient conditions (25 +/- 2 degrees C, 60 +/- 5% relative humidity). (c) 2021 Elsevier Ltd. All rights reserved. Selection and peer-review under responsibility of the scientific committee of the 1st International Conference on Computations in Materials and Applied Engineering - 2021.
引用
收藏
页码:394 / 402
页数:9
相关论文
共 32 条
[1]  
[Anonymous], 2018, EF MON IND PHARM 201, V2, P454
[2]   Indomethacin-saccharin cocrystal:: Design, synthesis and preliminary pharmaceutical characterization [J].
Basavoju, Srinivas ;
Bostrom, Dan ;
Velaga, Sitaram P. .
PHARMACEUTICAL RESEARCH, 2008, 25 (03) :530-541
[3]  
Bell RG, 2017, PAN STANF SER PHARM, V1, P573
[4]   Polymorphic Cocrystals of Nutraceutical Compound p-Coumaric Acid with Nicotinamide: Characterization, Relative Solid-State Stability, and Conversion to Alternate Stoichiometries [J].
Bevill, Melanie J. ;
Vlahova, Petinka I. ;
Smit, Jared P. .
CRYSTAL GROWTH & DESIGN, 2014, 14 (03) :1438-1448
[5]   Pharmaceutical cocrystals: The coming wave of new drug substances [J].
Brittain, Harry G. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (02) :311-317
[6]  
Cani E, 2019, SIDE EFFECT, P301, DOI 10.1016/bs.seda.2019.10.005
[7]   Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin [J].
Deng, Jun-Hui ;
Lu, Tong-Bu ;
Sun, Changquan Calvin ;
Chen, Jia-Mei .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 104 :255-261
[8]   THE HYDROGEN BOND IN ORGANIC CRYSTALS [J].
DONOHUE, J .
JOURNAL OF PHYSICAL CHEMISTRY, 1952, 56 (04) :502-510
[9]  
Efavirenz, DRUG BANK
[10]  
Efavirenz, PUBCHEM